You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Directional & Isotropic Diffusing Tips for Laser Therapy

    SBC: RARE EARTH MEDICAL, INC.            Topic: N/A

    N/A

    SBIR Phase I 1994 Department of Health and Human Services
  2. DIRECT ISOLATION OF 7Q311 CDNAS BY MICRODISSECTION

    SBC: OSCIENT PHARMACEUTICALS CORPORATION            Topic: N/A

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  3. DISPLACEMENT PURIFICATIONS OF ODNAS WITH NOVEL COLUMNS

    SBC: Omni Chrom, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  4. Display of Mrnas from Normal Tumorigenic Cells

    SBC: GENHUNTER CORPORATION            Topic: N/A

    Differential gene expression is a highly regulated process which controls normal cell growth anddifferentiation; its abnormality is the underlying cause of disease states such as cancer. Our objectiveis twofold: (1) to provide the biomedical research community with complete line of reagent systemsbased on the latest technological breakthrough known as Differential Display, (2) to use our expertise ...

    SBIR Phase I 1994 Department of Health and Human Services
  5. Disrupting Vital Protein Contacts in M Tuberculosis

    SBC: OSCIENT PHARMACEUTICALS CORPORATION            Topic: N/A

    The long term objective of this project is to develop a new class of drugs targeted to the disrupticontacts in the disease-causing microorganism Mycobacterium tuberculosis. The resurgence of tuberculworld and in the United States, particularly among those infected with HIV, emphasizes the need fordrugs. The specific aims of Phase I are to validate the two- hybrid interaction trap as an approachtub ...

    SBIR Phase I 1995 Department of Health and Human Services
  6. 3D Molecular Databases in Combinatorial Chemistry

    SBC: Molecular Simulations, Inc.            Topic: N/A

    Combinatorial Chemistry is the process whereby libraries of thousands to millions of chemical composynthesized and assayed for desirable biological activity. As the range of combinatorially accessibltools will be needed to help in selecting libraries suited for a particular purpose: finding drug ledetermining functional-group specificities in a congeneric series, exploring structural patterns forf ...

    SBIR Phase I 1995 Department of Health and Human Services
  7. DNA Probes for Gram Positive Periodontal Pathogens

    SBC: Omnigene Inc.            Topic: N/A

    Most diagnostic tests for periodontal pathogens have focused on enumeration of the major gram-negatassociated with diseased sites, although both gram-negative and gram-positive bacteria have been impagents of periodontal disease. The long-term objective of this project is to develop a DNA probe-basand quantitation of two gram-positive bacteria which have been associated with sites of periodontalPe ...

    SBIR Phase I 1995 Department of Health and Human Services
  8. Drug Design for Treatment of Inflammatory Bowel Disease

    SBC: Leukosite, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1995 Department of Health and Human Services
  9. Drug Screening Assay for Novel Chemotherapeutic Agents

    SBC: MATRITECH, INC.            Topic: N/A

    The nuclear matrix protein NuMA ( Nuclear Mitotic Apparatus) is present at greater than tenfold higmalignant tissues relative to normal tissues. Scientists at Matritech have shown that interference wantisense oligonucleotide technology dramatically slows the growth of cancer cells both in soft agarWe believe that the combination of its overexpression in cancerous tissue and its essential role form ...

    SBIR Phase I 1995 Department of Health and Human Services
  10. EAP MANAGED CARE & EVALUATION SYSTEM

    SBC: Development Associates            Topic: N/A

    THE OVERALL OBJECTIVE OF THE PROJECT IS TO DEVELOP AN EMPLOYEE ASSISTANCE PROGRAM MANAGED CARE AND EVALUATION SYSTEM (EAP/MCES) WHICH CONSISTS OF A PROCEDURES MANUAL, FORMS, AND IBM PC COMPATIBLE SOFTWARE WHICH CAN BE READILY ADAPTED TO THE MAJORITY OF EAP PROGRAMS. THE SYSTEM WILL BEUSER FRIENDLY AND THE PROCEDURES MANUAL WILL INCLUDE A TUTORIAL. THE SYSTEM WILL INCLUDE FOUR FUNCTIONS: CASE MANAG ...

    SBIR Phase I 1991 Department of Health and Human Services
US Flag An Official Website of the United States Government